Development of human serum albumin conjugated with near-infrared dye for photoacoustic tumor imaging

Abstract. Photoacoustic (PA) imaging has emerged as a noninvasive diagnostic method which detects ultrasonic waves thermoelastically induced by optical absorbers irradiated with laser. For tumor diagnosis, PA contrast agent has been proposed to enhance the PA effect for detecting tumors sensitively. Here, we prepared a human serum albumin (HSA) conjugated with indocyanine green (ICG) as a PA contrast agent allowing enhanced permeability and retention effect for sensitive tumor imaging. The feasibility of PA imaging with HSA-ICG to detect allografted tumors was evaluated in tumor-bearing mice. In vivo fluorescence imaging and radiolabeled biodistribution study showed that the biodistribution dramatically changed as the number of ICG bound to HSA increased, and the maximum accumulation of ICG was achieved when around three ICG molecules were loaded on an HSA. In vivo PA imaging demonstrated a tumor-selective and dose-dependent increase of PA signal intensity in mice injected with HSA-ICG (R2=0.88, 387% increase for HSA-ICG, 104 nmol ICG). In conclusion, HSA-ICG clearly visualized the allografted tumors with high tumor-to-background ratios having high quantitative and spatial resolution for the sensitive PA imaging of tumors. HSA-ICG could be useful as a favorable contrast agent for PA tumor imaging for the management of cancer.

[1]  C. S. Davidson,et al.  Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. , 1960, The Journal of clinical investigation.

[2]  J L Tullis,et al.  Albumin. 2. Guidelines for clinical use. , 1977, JAMA.

[3]  D A Rickaby,et al.  Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction , 1984, British journal of pharmacology.

[4]  B. Erstad,et al.  A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. , 1995, Archives of internal medicine.

[5]  T W Evans,et al.  Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressure , 2002, Alimentary pharmacology & therapeutics.

[6]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[7]  Andrew S Gurwood,et al.  Intravenous and indocyanine green angiography. , 2004, Optometry.

[8]  Craig J McClain,et al.  Albumin therapy in clinical practice. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[9]  Geng Ku,et al.  Deeply penetrating photoacoustic tomography in biological tissues enhanced with an optical contrast agent. , 2005, Optics letters.

[10]  Sheng-Wen Huang,et al.  Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. , 2007, Journal of biomedical optics.

[11]  S. Sakka,et al.  Assessing liver function , 2007, Current opinion in critical care.

[12]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[13]  Haifang Wang,et al.  Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. , 2008, Toxicology letters.

[14]  V. Ntziachristos.  Going deeper than microscopy: the optical imaging frontier in biology , 2010, Nature Methods.

[15]  Hiroshi Maeda,et al.  Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. , 2010, Bioconjugate chemistry.

[16]  Manojit Pramanik,et al.  Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. , 2010, Biomaterials.

[17]  Feng Gao,et al.  In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. , 2010, ACS nano.

[18]  Stanislav Y. Emelianov,et al.  Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents , 2011, Annals of Biomedical Engineering.

[19]  S. Emelianov,et al.  Tissue-mimicking phantoms for photoacoustic and ultrasonic imaging , 2011, Biomedical optics express.

[20]  Hiroshi Maeda,et al.  EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. , 2011, Advanced drug delivery reviews.

[21]  Sanjiv S Gambhir,et al.  Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics. , 2011, Contrast media & molecular imaging.

[22]  Vasilis Ntziachristos,et al.  Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery. , 2012, Current pharmaceutical biotechnology.

[23]  Hisataka Kobayashi,et al.  In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores , 2012, Breast Cancer Research.

[24]  Sanjiv S Gambhir,et al.  Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice. , 2012, ACS nano.

[25]  Felix Kratz,et al.  Impact of albumin on drug delivery--new applications on the horizon. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Lihong V. Wang,et al.  Förster resonance energy transfer photoacoustic microscopy , 2012, Photonics West - Biomedical Optics.

[27]  Jan Laufer,et al.  In vivo preclinical photoacoustic imaging of tumor vasculature development and therapy. , 2012, Journal of biomedical optics.

[28]  Jun Fang,et al.  S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects. , 2012, Bioconjugate chemistry.

[29]  Samuel Achilefu,et al.  Multimodal sentinel lymph node mapping with single-photon emission computed tomography (SPECT)/computed tomography (CT) and photoacoustic tomography. , 2012, Translational research : the journal of laboratory and clinical medicine.

[30]  S. Emelianov,et al.  Photoacoustic Imaging for Cancer Detection and Staging. , 2013, Current molecular imaging.

[31]  Hisataka Kobayashi,et al.  Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes. , 2013, Bioconjugate chemistry.

[32]  Insook Kim,et al.  Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging , 2013, Journal of biomedical optics.

[33]  Peng Huang,et al.  In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars. , 2014, Small.

[34]  Lihong V. Wang,et al.  Multicontrast photoacoustic in vivo imaging using near-infrared fluorescent proteins , 2014, Scientific Reports.